Bosnia and Herzegovina vs Italy: Number of people diagnosed with new episode of pulmonary TB who are
Bosnia and Herzegovina
56
in 2021
Italy
53
in 2021
Bosnia and Herzegovina rank
124th
Italy rank
126th
Number of people diagnosed with new episode of pulmonary TB who are over time
- Bosnia and Herzegovina
- Italy
How they compare
Bosnia and Herzegovina currently reports 56 against 53 in Italy, a difference of 3.
That makes Bosnia and Herzegovina's figure about 1.1 times Italy's.
The two have swapped places 8 times across 22 shared years of data; in 2000 it was Bosnia and Herzegovina ahead.
Bosnia and Herzegovina ranks 124th and Italy ranks 126th of 214 countries.
Italy has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Bosnia and Herzegovina | Italy | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 1,049 | 1,428 | 379.1 | Italy |
| 2010s | 344.5 | 581.5 | 237 | Italy |
| 2020s | 67.5 | 141 | 73.5 | Italy |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher number of people diagnosed with new episode of pulmonary tb who are, Bosnia and Herzegovina or Italy?
- Bosnia and Herzegovina, at 56 against 53 in Italy as of 2021.
- What is the difference in number of people diagnosed with new episode of pulmonary tb who are between Bosnia and Herzegovina and Italy?
- 3, with Bosnia and Herzegovina ahead.
- How many years of comparable data are there for Bosnia and Herzegovina and Italy?
- 22 years are reported by both, from 2000 to 2021.
- How do Bosnia and Herzegovina and Italy rank globally for number of people diagnosed with new episode of pulmonary tb who are?
- Bosnia and Herzegovina ranks 124th and Italy ranks 126th of 214 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Number of people diagnosed with new episode of pulmonary TB who are clinically diagnosed.. Statizoid refreshes it automatically from the source and publishes the full history for both places.